Vermont

About State and Territory Profiles

View state and national data for select objectives, follow links to learn more about the data sources and methodology, and find resources like state and territory health improvement plans and related evidence-based resources (EBRs).

Only those Healthy People 2030 national objectives for which reliable state and/or territory data are available will be shown. More objectives will be added to this page over time.

Note: Healthy People targets for these objectives are not included, because they only apply to the national data.

Review the Data Methodology and Measurement sections of each objective by clicking the links below each objective. Any differences in analytic methods will be noted on that objective’s corresponding Data and Data Methodology and Measurement pages. Learn more about the Healthy People data sources and methods.

Vermont Health Improvement Plan

See which Leading Health Indicators are addressed in this state or territory health improvement plan.

View the plan [PDF - 798 KB]

Note: The objectives listed below are not necessarily included in the state and territory health improvement plans. Leading Health Indicators (LHIs) are a small subset of objectives that were developed based on national data. LHIs are not based on state- or territory-level health priorities.

Objectives with data for Vermont (26)

Cancer Workgroup

Reduce the overall cancer death rate — C‑01 (cancer deaths per 100,000 population) ^*

139.4 United States (2024)

144.1 Vermont (2024)

Reduce the lung cancer death rate — C‑02 (lung cancer deaths per 100,000 population) ^*

28.0 United States (2024)

29.4 Vermont (2024)

Reduce the female breast cancer death rate — C‑04 (breast cancer deaths per 100,000 females) ^*

18.7 United States (2024)

15.6 Vermont (2024)

Reduce the colorectal cancer death rate — C‑06 (colorectal cancer deaths per 100,000 population) ^*

12.6 United States (2024)

11.7 Vermont (2024)

Reduce the prostate cancer death rate — C‑08 (prostate cancer deaths per 100,000 males) ^*

18.2 United States (2024)

18.7 Vermont (2024)

Heart Disease and Stroke Workgroup

Reduce coronary heart disease deaths — HDS‑02 (coronary heart disease deaths per 100,000 population) ^*

78.6 United States (2024)

85.9 Vermont (2024)

Reduce stroke deaths — HDS‑03 (stroke deaths per 100,000 population) ^*

38.6 United States (2024)

24.4 Vermont (2024)

Immunization and Infectious Diseases Workgroup

Reduce the rate of deaths with hepatitis C as a cause — IID‑16 (deaths with hepatitis C as the underlying or contributing cause per 100,000 population) ^*

2.25 United States (2024)

2.47 Vermont (2024)

Injury and Violence Prevention Workgroup

Reduce fatal injuries — IVP‑01 (deaths per 100,000 population) ^*

74.8 United States (2024)

91.3 Vermont (2024)

Reduce unintentional injury deaths — IVP‑03 (deaths per 100,000 population) ^*

53.3 United States (2024)

71.0 Vermont (2024)

Reduce fatal traumatic brain injuries — IVP‑05 (deaths per 100,000 population) ^*

18.0 United States (2024)

20.4 Vermont (2024)

Reduce deaths from motor vehicle crashes — IVP‑06 (motor vehicle traffic-related deaths per 100,000 population) ^*

11.6 United States (2024)

8.6 Vermont (2024)

Reduce fall-related deaths among older adults — IVP‑08 (deaths per 100,000 population) ^* ^◊

78.1 United States (2024)

147.3 Vermont (2024)

Reduce homicides — IVP‑09 (homicides per 100,000 population) ^*

This objective is a Leading Health Indicator (LHI). Learn about LHIs.

6.2 United States (2024)

3.2 Vermont (2024)

Reduce firearm-related deaths — IVP‑13 (firearm-related deaths per 100,000 population) ^*

12.8 United States (2024)

10.6 Vermont (2024)

Reduce overdose deaths involving opioids — IVP‑20 (deaths per 100,000 population) ^*

16.0 United States (2024)

29.0 Vermont (2024)

Reduce overdose deaths involving natural and semisynthetic opioids — IVP‑21 (deaths per 100,000 population) ^*

2.3 United States (2024)

1.9 Vermont (2024)

Reduce overdose deaths involving synthetic opioids other than methadone — IVP‑22 (deaths per 100,000 population) ^*

14.3 United States (2024)

27.7 Vermont (2024)

Reduce overdose deaths involving heroin — IVP‑23 (deaths per 100,000 population) ^*

1.2 United States (2023)

1.6 Vermont (2023)

Reduce overdose deaths involving methadone — IVP‑24 (deaths per 100,000 population) ^*

0.92 United States (2024)

3.35 Vermont (2024)

Maternal, Infant, and Child Health Workgroup

Reduce the rate of deaths in children and adolescents aged 1 to 19 years — MICH‑03 (deaths among children and adolescents aged 1 to 19 years per 100,000 population) ^◊

27.0 United States (2024)

25.1 Vermont (2024)

Mental Health and Mental Disorders Workgroup

Reduce the suicide rate — MHMD‑01 (suicides per 100,000 population) ^*

This objective is a Leading Health Indicator (LHI). Learn about LHIs.

13.7 United States (2024)

14.7 Vermont (2024)

Respiratory Diseases Workgroup

Reduce asthma deaths — RD‑01 (asthma deaths per 1,000,000 population) ^*

9.6 United States (2023)

15.5 Vermont (2023)

Reduce deaths from COPD in adults — RD‑05 (COPD deaths per 100,000 adults) ^* ^◊

89.1 United States (2024)

82.9 Vermont (2024)

Substance Use Workgroup

Reduce cirrhosis deaths — SU‑02 (cirrhosis deaths per 100,000 population) ^*

12.7 United States (2024)

11.3 Vermont (2024)

Reduce drug overdose deaths — SU‑03 (drug overdose deaths per 100,000 population) ^*

This objective is a Leading Health Indicator (LHI). Learn about LHIs.

23.1 United States (2024)

33.6 Vermont (2024)

About State and Territory Profiles

Vermont Health Improvement Plan

Objectives with data for Vermont (26)

Reduce the overall cancer death rate — C‑01 (cancer deaths per 100,000 population) *

Reduce the lung cancer death rate — C‑02 (lung cancer deaths per 100,000 population) *

Reduce the female breast cancer death rate — C‑04 (breast cancer deaths per 100,000 females) *

Reduce the colorectal cancer death rate — C‑06 (colorectal cancer deaths per 100,000 population) *

Reduce the prostate cancer death rate — C‑08 (prostate cancer deaths per 100,000 males) *

Reduce coronary heart disease deaths — HDS‑02 (coronary heart disease deaths per 100,000 population) *

Reduce stroke deaths — HDS‑03 (stroke deaths per 100,000 population) *

Reduce the rate of deaths with hepatitis C as a cause — IID‑16 (deaths with hepatitis C as the underlying or contributing cause per 100,000 population) *

Reduce fatal injuries — IVP‑01 (deaths per 100,000 population) *

Reduce unintentional injury deaths — IVP‑03 (deaths per 100,000 population) *

Reduce fatal traumatic brain injuries — IVP‑05 (deaths per 100,000 population) *

Reduce deaths from motor vehicle crashes — IVP‑06 (motor vehicle traffic-related deaths per 100,000 population) *

Reduce fall-related deaths among older adults — IVP‑08 (deaths per 100,000 population) * ◊

Reduce homicides — IVP‑09 (homicides per 100,000 population) *

Reduce firearm-related deaths — IVP‑13 (firearm-related deaths per 100,000 population) *

Reduce overdose deaths involving opioids — IVP‑20 (deaths per 100,000 population) *

Reduce overdose deaths involving natural and semisynthetic opioids — IVP‑21 (deaths per 100,000 population) *

Reduce overdose deaths involving synthetic opioids other than methadone — IVP‑22 (deaths per 100,000 population) *

Reduce overdose deaths involving heroin — IVP‑23 (deaths per 100,000 population) *

Reduce overdose deaths involving methadone — IVP‑24 (deaths per 100,000 population) *

Reduce the rate of deaths in children and adolescents aged 1 to 19 years — MICH‑03 (deaths among children and adolescents aged 1 to 19 years per 100,000 population) ◊

Reduce the suicide rate — MHMD‑01 (suicides per 100,000 population) *

Reduce asthma deaths — RD‑01 (asthma deaths per 1,000,000 population) *

Reduce deaths from COPD in adults — RD‑05 (COPD deaths per 100,000 adults) * ◊

Reduce cirrhosis deaths — SU‑02 (cirrhosis deaths per 100,000 population) *

Reduce drug overdose deaths — SU‑03 (drug overdose deaths per 100,000 population) *

Reduce the overall cancer death rate — C‑01 (cancer deaths per 100,000 population) ^*

Reduce the lung cancer death rate — C‑02 (lung cancer deaths per 100,000 population) ^*

Reduce the female breast cancer death rate — C‑04 (breast cancer deaths per 100,000 females) ^*

Reduce the colorectal cancer death rate — C‑06 (colorectal cancer deaths per 100,000 population) ^*

Reduce the prostate cancer death rate — C‑08 (prostate cancer deaths per 100,000 males) ^*

Reduce coronary heart disease deaths — HDS‑02 (coronary heart disease deaths per 100,000 population) ^*

Reduce stroke deaths — HDS‑03 (stroke deaths per 100,000 population) ^*

Reduce the rate of deaths with hepatitis C as a cause — IID‑16 (deaths with hepatitis C as the underlying or contributing cause per 100,000 population) ^*

Reduce fatal injuries — IVP‑01 (deaths per 100,000 population) ^*

Reduce unintentional injury deaths — IVP‑03 (deaths per 100,000 population) ^*

Reduce fatal traumatic brain injuries — IVP‑05 (deaths per 100,000 population) ^*

Reduce deaths from motor vehicle crashes — IVP‑06 (motor vehicle traffic-related deaths per 100,000 population) ^*

Reduce fall-related deaths among older adults — IVP‑08 (deaths per 100,000 population) ^* ^◊

Reduce homicides — IVP‑09 (homicides per 100,000 population) ^*

Reduce firearm-related deaths — IVP‑13 (firearm-related deaths per 100,000 population) ^*

Reduce overdose deaths involving opioids — IVP‑20 (deaths per 100,000 population) ^*

Reduce overdose deaths involving natural and semisynthetic opioids — IVP‑21 (deaths per 100,000 population) ^*

Reduce overdose deaths involving synthetic opioids other than methadone — IVP‑22 (deaths per 100,000 population) ^*

Reduce overdose deaths involving heroin — IVP‑23 (deaths per 100,000 population) ^*

Reduce overdose deaths involving methadone — IVP‑24 (deaths per 100,000 population) ^*

Reduce the rate of deaths in children and adolescents aged 1 to 19 years — MICH‑03 (deaths among children and adolescents aged 1 to 19 years per 100,000 population) ^◊

Reduce the suicide rate — MHMD‑01 (suicides per 100,000 population) ^*

Reduce asthma deaths — RD‑01 (asthma deaths per 1,000,000 population) ^*

Reduce deaths from COPD in adults — RD‑05 (COPD deaths per 100,000 adults) ^* ^◊

Reduce cirrhosis deaths — SU‑02 (cirrhosis deaths per 100,000 population) ^*

Reduce drug overdose deaths — SU‑03 (drug overdose deaths per 100,000 population) ^*